Clinical trials have found that tirzepatide can produce greater average weight loss than semaglutide, in some cases by several additional percentage points
In patients experiencing clinically significant WR, our findings demonstrate substantial diminishment of %EWL from 63.3% at one year to 34.1% by year two
Therefore, from the maximum dose of 3mg, the patient stays on this dose for 1-2 weeks, then gets reduced to 2.4mg, then 1.8mg, then 1.2mg, then 0.6mg for 1-2 weeks, and then stops treatment
/ autor: Weronika Rumiska Stosowanie popularnego leku wspomagajcego odchudzanie bez skutkw ubocznych
Notably, intake of a low-carbohydrate diet did not exert the same effect